Active Not RecruitingNCT05870111
Citicoline or placebo and brain and immune measures in teens who drink alcohol
Medication studyAges 16–22United StatesAddiction
Understand this study
Who could participate?
Listed age limits: 16 years to 22 years.
- Listed locations
- CharlestonSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: October 1, 2024
- Recruitment status
- Active Not Recruiting
- Enrollment listed in the registry
- 56
- Sponsor
- Medical University of South Carolina
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 16 Years to 22 Years
- Official registry ID
- NCT05870111
- Official title
Show the full official title
Neurobehavioral and Immune Effects of Citicoline in Youth Alcohol Use Disorder
Recruitment & locations
Not recruitingThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Charleston
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Medical University of South Carolina, a university.
Does this study involve medication?
Yes. The study involves medication, including Citicoline (cytidine diphosphate-choline) and Placebo oral capsule.
Who can participate?
Listed age limits: 16 years to 22 years.
Is this study still recruiting?
The registry lists this study as active, but no longer recruiting.
